checkAd
    Startseite > Aktien > Cytosorbents > Nachrichten
    Cytosorbents Aktie
    0,7740
     
    EUR
    +2,65 %
    +0,0200 EUR
    Letzter Kurs 20:53:15 Quotrix Düsseldorf
    0,7460
     
    EUR
    2.020 STK
    Geldkurs 20:53:15
    0,8020
     
    EUR
    2.020 STK
    Briefkurs 20:53:15
    ISIN: US23283X2062 · WKN: A12GDU · SYM: HQE1 · USA

    Neueste Nachrichten

    CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe
    13:00 Uhr · globenewswire · Cytosorbents
    CytoSorbents to Report First Quarter 2024 Operating and Financial Results
    26.04.24 · globenewswire · Cytosorbents
    STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
    17.04.24 · globenewswire · Cytosorbents
    CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
    14.03.24 · globenewswire · Cytosorbents
    CytoSorbents to Report Fiscal 2023 Operating and Financial Results
    06.03.24 · globenewswire · Cytosorbents
    CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
    08.02.24 · globenewswire · Cytosorbents
    Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb Intraoperatively in Heart Transplant Patients
    17.01.24 · globenewswire · Cytosorbents
    CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
    28.12.23 · globenewswire · Cytosorbents
    CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
    09.11.23 · globenewswire · Cytosorbents
    CytoSorbents to Report Third Quarter 2023 Operating and Financial Results
    27.10.23 · globenewswire · Cytosorbents
    CytoSorbents to Present at the 8th Annual Dawson James Conference
    05.10.23 · globenewswire · Cytosorbents
    CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry
    27.09.23 · globenewswire · Cytosorbents